Viewing data from:

KURVELO

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A091408 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.1125

per ea

Lowest NADAC/Unit

$0.1125

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68180084473KURVELO-28 TABLET	$0.1125	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

Medicare Part D Spending

CMS annual spending data for Kurvelo (2024)

Total Spending

$104K

Total Claims

4,326

Beneficiaries

1,149

Avg Cost/Unit

$0.39

Spending Trend

$95K(2019)→$107K(2020)→$103K(2021)→$89K(2022)→$109K(2023)→$104K(2024)

YoY Change:-18.1%

5yr CAGR:-6.9%

Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG;0.15MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Oct 17, 2012

No patent or exclusivity listings for this strength.